chf

Mainstay confirms its continued eligibility to the PEA-PME

on 12/01/2015 11:09

Nexstim adds Chronic Neuropathic Pain Therapy to its clinical indication pipeline with co-operation agreement with the Walton Center

on 16/12/2014 16:53
Nexstim announces a co-operation agreement with The Walton Centre
Read more

Mainstay Medical achieves Quality System Certification

on 09/12/2014 14:25
Certification is an important step towards the commercialisation of ReActiv8.
Read more

Mainstay Medical - Interim Management Statement

on 06/11/2014 10:59
Continued progress towards commercialisation of ReActiv8®
Read more

World first, as patient receives an implanted pump system to manage pleural effusions

on 05/11/2014 10:51
Sequana Medical’s innovative technology enables the automated management of excess fluid around the lungs for the first time ever
Read more